The success of Viagra initially sparked a period of growth for pharma, nevertheless recent changes present a uncertain outlook for shareholders. Off-patent competitors are eating into revenue, and continued legal battles add additional difficulty to the landscape. While certain companies could still benefit from adjacent services, the overall di… Read More